Citation Tools
PDFRegular and young investigator award abstracts
Clinical trials in progress
363 Vactosertib and durvalumab as second or later line treatment for PD-L1 positive non-small cell lung cancer: interim result
Download to a citation manager
Download the citation for this article by clicking on one of the following citation managers:
- Cite this article as:
- 363 Vactosertib and durvalumab as second or later line treatment for PD-L1 positive non-small cell lung cancer: interim result